PET, MRI study provides clues on Tourette Syndrome

11/21/2012 | Medscape (free registration)

Researchers using PET with carbon-11 flumazenil and structural MRI found that patients with Tourette Syndrome have lower binding of gamma-aminobutyric acid-ergic receptors in the ventral striatum, globus pallidus, thalamus, amygdala and right insula. The study findings are consistent with long-held theories about the disease concerning the disinhibition of particular circuits in the brain.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC